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Abstract
Profilins are prominent regulators of actin dynamics. While most mammalian cells express only one profilin, two isoforms,
PFN1 and PFN2a are present in the CNS. To challenge the hypothesis that the expression of two profilin isoforms is linked to
the complex shape of neurons and to the activity-dependent structural plasticity, we analysed how PFN1 and PFN2a
respond to changes of neuronal activity. Simultaneous labelling of rodent embryonic neurons with isoform-specific
monoclonal antibodies revealed both isoforms in the same synapse. Immunoelectron microscopy on brain sections
demonstrated both profilins in synapses of the mature rodent cortex, hippocampus and cerebellum. Both isoforms were
significantly more abundant in postsynaptic than in presynaptic structures. Immunofluorescence showed PFN2a associated
with gephyrin clusters of the postsynaptic active zone in inhibitory synapses of embryonic neurons. When cultures were
stimulated in order to change their activity level, active synapses that were identified by the uptake of synaptotagmin
antibodies, displayed significantly higher amounts of both isoforms than non-stimulated controls. Specific inhibition of
NMDA receptors by the antagonist APV in cultured rat hippocampal neurons resulted in a decrease of PFN2a but left PFN1
unaffected. Stimulation by the brain derived neurotrophic factor (BDNF), on the other hand, led to a significant increase in
both synaptic PFN1 and PFN2a. Analogous results were obtained for neuronal nuclei: both isoforms were localized in the
same nucleus, and their levels rose significantly in response to KCl stimulation, whereas BDNF caused here a higher increase
in PFN1 than in PFN2a. Our results strongly support the notion of an isoform specific role for profilins as regulators of actin
dynamics in different signalling pathways, in excitatory as well as in inhibitory synapses. Furthermore, they suggest a
functional role for both profilins in neuronal nuclei.
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Introduction
The actin cytoskeleton determines birth, maintenance, function
and structural plasticity of neuronal synapses. In the presynapse,
an actin filament meshwork regulates the release and recycling of
neurotransmitter containing vesicles [1]. At the postsynapse, actin
is involved in converting neuronal activity into structural changes
(reviewed in [2]). Thus, the morphology of dendritic spines, the
postsynaptic structures that mainly receive the excitatory input,
depends on the dynamics of actin [3] that in turn is regulated by
numerous actin-binding proteins.
Prominent regulators of neuronal actin dynamics are profilins
(reviewed in [4]). In the mammalian and avian CNS, two isoforms,
profilin 1 (PFN1) and profilin 2a (PFN2a), are co-expressed [5,6],
with PFN2a contributing up to 75% of the total profilin [7]. PFN1
is expressed in all mammalian cells, but in quite variable amounts
in different brain regions [8]. In addition to a general role in
neuritogenesis [9,10], it may exert specific functions in neuronal
subpopulations [10]. Biochemical data demonstrated interactions
of PFN1 and PFN2a with pre- and postsynaptic proteins
[11,12,13,14,15].
Genetic, physiological and biochemical studies have led to
controversal interpretations on the role of PFN2a in synaptic
architecture and function. Biochemical data revealed PFN2a
associated with effectors of exocytotic and endocytotic pathways
[6] and suggested its involvement in the assembly of the
endocytotic machinery [16]. Furthermore, a mouse mutant with
a deleted pfn2 gene displays an increase in synaptic vesicle
exocytosis [8], consistent with an inhibitory role for PFN2a in the
control of presynaptic membrane trafficking. On the other hand,
overexpressed PFN2a was observed to translocate into dendritic
spines of cultured neurons in an activity-dependent manner
[17,18], and fear conditioning correlated with profilin enrichment
in dendritic spines of rat amygdalae [19]. Hence, both studies
PLoS ONE | www.plosone.org 1 March 2012 | Volume 7 | Issue 3 | e34167suggested an important, if not unique role for PFN2a at the
postsynapse.
More recent findings showed that PFN1 and PFN2a have
overlapping as well as differential effects on dendritic architecture:
The physiological level of PFN2a is essential for normal dendritic
complexity and spine numbers, but in neurons with decreased
PFN2a, PFN1 can only rescue spine numbers, not dendritic
complexity [20].
To unravel the functional differences between PFN1 and
PFN2a in more detail, we first determined their endogenous levels
in synaptic structures of cultured rodent neurons, in sections of
mature rat cortex, hippocampus and cerebellum and in neuronal
nuclei. Using isoform specific monoclonal antibodies in immuno-
fluorescence and immunoelectron microscopy, we detected both
isoforms in the same neuronal compartment. Furthermore, we
report that they differentially respond to changes in neuronal
activity. These data reveal that PFN1 and PFN2a are linked to
different signalling pathways.
Results
Primary hippocampal neurons express both PFN isoforms
in the same synaptic structures
To visualise both profilin isoforms in cultured embryonic
neurons, we used a pair of monoclonal antibodies (mABs) specific
for PFN1 and PFN2a, (Figure 1). The antibody mAB 4H5,
generated against bovine brain PFN2a, recognises a PFN2a-
specific epitope at the C-terminus in mammals and in birds [5],
while mAB 2C5 is directed against an N-terminal peptide
sequence of PFN1 that was fused to a nanoparticle carrier [21]
By pre-labelling of one mAB and using two different fluorophores
(see Material and Methods) we localised PFN1 and PFN2a
simultaneously in the same cultured embryonic neuron (DIV14)
derived from murine hippocampus (Figure 2), and counterstaining
for synapsin revealed both isoforms within the same synaptic
structures. In general, the PFN1 signal was also seen along the
neurites, while PFN2a was more strictly confined to synapses
(Figure 2).
Both profilin isoforms are predominantly localised in the
postsynaptic compartment of different brain regions
For an unequivocal assignment of PFN1 and PFN2a to pre- and
postsynaptic structures, we performed immunoelectron microsco-
py on ultrathin sections derived from different regions of the adult
rat brain. The presynaptic compartment was identified by the
density of neurosecretory vesicles, and corroborated by pre-
embedding immunogold labelling with antibodies against synap-
tophysin (Figure 3A) whereas adjacent structures were recognised
as postsynaptic spines. Immunogold labelling with anti-PFN1 and
anti-PFN2a revealed both proteins in both compartments
(Figure 3A). Notably, quantitation of the gold particles showed
that both isoforms were more abundant in post- than in
presynapses. Moreover, PFN2a labelling was more prominent
than PFN1, with a noticeable accumulation at the cytoplasmic face
of the postsynaptic density, similar to the previously reported
localisation of the profilin-ligand Mena [22] (Figure 3B). These
data corroborate previous reports demonstrating that PFN2a is
more frequent in rodent brain than PFN1 [7].
PFN2a colocalises with gephyrin clusters at inhibitory
synapses
The higher abundance of PFN2a in postsynaptic than
presynaptic structures of different brain regions led us to study
profilins in different subtypes of synapses. To reveal the isoform
localisation in inhibitory synapses, we again labelled cultured
mouse hippocampal neurons with the isoform-specific mABs
simultaneously, and counterstained the samples with an antibody
against gephyrin, a component of the postsynaptic protein network
of inhibitory synapses and a ligand of both profilin isoforms [12].
PFN1 and PFN2a were both detected in inhibitory synapses
(Figure 4), but they clearly differed in their extent of co-localisation
with gephyrin: PFN1 was diffusely spread throughout dendrites
and only occasionally accumulated at gephyrin clusters, whereas
PFN2a was primarily concentrated in bright spots that coincided
with gephyrin clusters along dendrites (Figure 4A, left and centre
columns). Because gephyrin is not confined to the postsynaptic
compartment [23,24], we counterstained PFN2a- and gephyrin-
labelled neurons for the presynaptic marker VGAT that is
restricted to inhibitory synapses [25]. We found PFN2a preferen-
tially associated with large gephyrin clusters adjacent to VGAT-
positive synaptic terminals, whereas smaller extra-synaptic ge-
phyrin spots were mostly negative for PFN2a (Figure 4, right
column). Quantitation of the PFN2a, VGAT and gephyrin signals
confirmed that in inhibitory neurons, PFN2a is primarily
concentrated at the synaptic gephyrin clusters of postsynaptic
terminals. Figure 4B shows that gephyrin clusters not associated
with synapses comprise only approximately 10% of the total.
The levels of profilins correspond to synaptic activity
To study whether the synaptic presence of profilins is subject to
activity changes, we induced global synaptic activity in hippo-
campal rat neurons (DIV15) by high K
+-depolarisation, and
stained for piccolo and the two profilin isoforms (Figure 5).
Piccolo, an active zone protein is unresponsive to activity
modulation [26] and thus serves as a marker for all synaptic
terminals irrespective of their activity level. To visualise selectively
those synapses that are actively undergoing cycles of exo- and
endocytosis high K
+-depolarisation was performed in the presence
of an antibody directed against the luminal domain of the synaptic
vesicle (SV) protein synaptotagmin 1. Labelling synaptic structures
by such an antibody serves as a faithful marker of synaptic activity,
as it is only taken up when SVs undergo cycles of exo- and
endocytosis [27,28]. The immunofluorescence images in Figure 5A
clearly show that the signal strength for both profilin isoforms
markedly increases after KCl mediated activity stimulation.
Quantification of fluorescence intensities of PFN1 and PFN2a
immunoreactivity revealed a significant increase of PFN1 and
PFN2a at synapses upon synaptic activity (Figure 5B).
Because an NMDA receptor-dependent translocation of PFN2a
into dendritic spines has been described for neurons that
overexpress PFN2a [17], we examined whether also endogenous
profilins correspond accordingly to NMDA receptor activity.
Neurons were stimulated with high K
+ in the presence of the
NMDA receptor antagonist APV. They were simultaneously
immunostained for PFN1 and PFN2a, and synapses were
identified by labelling with anti-synapsin. The fluorescence signal
at a synapse divided by the neurite level was used to calculate the
enrichment factor, which confirmed that both profilins are
enriched in synapses after KCl stimulation (Figure 5C). Consistent
with the data obtained for dendritic spines in neurons overex-
pressing PFN2a [17], blocking of NMDA receptors by APV
resulted in a significant decrease of PFN2a in synaptic structures.
However, this effect was not seen for PFN1 (Figure 5C). This
indicates that the response of PFN1 to increased neuronal activity
is not linked to NMDA receptor activation.
These data suggest that PFN1 is involved in a signalling
pathway that is also triggered by KCl but different from the
PFN Isoforms Are Addressed by Different Pathways
PLoS ONE | www.plosone.org 2 March 2012 | Volume 7 | Issue 3 | e34167Figure 1. Specificity of the monoclonal antibodies raised against PFN1 (2C5) or PFN2a (4H5). (A): Isoform-specific epitopes recognised by
the monoclonal antibodies 2C5 and 4H5, as determined by pepscan analysis on overlapping 15mer amino acid sequences, as described [51]. Their
respective location on the surface of PFN1 or PFN2a (blue) is indicated in the structural models designed by using Pymol software (DeLano Scientific
LLC, Palo Alto, USA, version 0.98). (B): PFN isoform specific reactivity of 2C5 and 4H5. (B1): Immunoblot of 2C5 with purified recombinant mouse PFN1,
mouse brain PFN2a and total extract of mouse spleen. (B2): Dot blot (left) and immunoblot (right) of 4H5 with recombinant mouse PFN1, mouse brain
PFN2a and total brain extract. BSA: bovine serum albumin used as control. (C): Confocal images of immunofluorescence with 2C5 (upper panels) and
4H5 (lower panels) of C2C12 mouse myoblasts transfected with GFP-PFN2a. The antibody 2C5 reveals a typical fine diffuse cytoplasmic, but also a
nuclear staining for PFN1, while the PFN2a specific antibody 4H5 labels only the GFP-PFN2a transfected cells (lower left) as part of a C2C12 cell
population (DIC image; lower right). Filamentous actin was stained with FITC-phalloidin. Bars: 10 mm.
doi:10.1371/journal.pone.0034167.g001
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PLoS ONE | www.plosone.org 3 March 2012 | Volume 7 | Issue 3 | e34167NMDA receptor cascade. Several receptors of neurotrophic
factors are well-known modulators of neuronal morphology and
activity dependent structural plasticity. For example, neuronal
activation by high KCl stimulates the secretion of BDNF [29], and
binding of this neurotrophin to TrkB receptors at the pre- and
postsynaptic site will then trigger a large variety of signalling
pathways [30]. This can lead to structural changes of synapses that
are most likely mediated by the actin cytoskeleton [31,32]. To
address the question whether profilin isoforms could account for
BDNF-dependent morphological alterations we activated the
TrkB receptor pathway. Therefore, we stimulated hippocampal
neurons with BDNF, immunostained them for either PFN1 or
PFN2a and synapsin (Figure 6A), and calculated the enrichment
factor for profilin at synapses. The data clearly show that BDNF
stimulation caused a significant increase in synaptic PFN1 and
PFN2a (Figure 6 B) and that, in contrast to the NMDA receptor
activity, both isoforms respond to BDNF-induced TrkB receptor
activity in the same manner.
PFN1 and PFN2a are both constituents of neuronal nuclei
Since trafficking of profilin to the nucleus [18] and its
interaction with nuclear ligands [33,34,35,36] have been reported,
we specifically examined the nuclear compartment of cultivated
neurons for the presence of PFN1 and PFN2a. Immunofluores-
cence and quantitation of the fluorescence signals in the cytosol
and the nucleus were performed (Figure 7). Both isoforms were
present in the nucleus of non-stimulated neurons (Figure 7A). The
signal for PFN1 was generally higher in the cytosol than in the
nucleus, while PFN2a was frequently enriched in the nucleus
(Figure 7A, control). Comparison of the respective fluorescence
intensity in nuclei and cytosol of stimulated and unstimulated
neurons showed that KCl stimulation significantly increased the
nuclear level of PFN1 and PFN2a by 40%, while the amounts in
the cytoplasm remained constant (Figure 7B). Blocking the NMDA
receptor by APV (Figure 7C) resulted in a slight increase (20%) of
both isoforms in the nucleus, with a concomitant decrease of the
cytoplasmic level of PFN1 (50%; P,0.005), while the amount of
cytoplasmic PFN2a remained almost constant (Figure 7C).
Subsequently, we asked whether activation of the TrkB receptor
pathway could alter the amount of profilins in the nucleus.
Consistent with the effect on synaptic profilins, the addition of
BDNF caused a significant rise in nuclear PFN1 by 80%, whereas
no significant alterations in the cytoplasmic and nuclear level of
PFN2a were seen (Figure 7A,D).
Taken together, these data indicate that BDNF stimulation led
to an increase of both profilin isoforms in the synapse concomitant
with a significant rise of nuclear PFN1.
Discussion
Here we present a detailed study on the differential localisation
of the profilin isoforms PFN1 and PFN2a in cultured embryonic
neurons and in the adult brain of mouse and rat. In contrast to
previous studies that used either overexpressed profilins [17,18] or
focussed selectively on one profilin isoform [8,10,14,16], we
assessed the localisation and the level of both endogenous profilin
isoforms within one neuronal compartment. By means of two
monoclonal mouse antibodies, we detected PFN1 and PFN2a in
the same synaptic structure and in neuronal nuclei. PFN2a
preferentially accumulates in discrete patterns in the majority of
synapses, whereas PFN1 is only rarely enriched in synapses as
compared to the neurite. This differential distribution is in
agreement with a previous study that focused on endogenous
PFN1 and demonstrated a high amount of this isoform in only a
minority of synapses of cultured neurons and also in the adult
brain [10]. These findings raise the question whether PFN1 has a
specific role in a subpopulation of so far undefined neurons or
might only be present in a subtype of synapses with e.g. different
postsynaptic structures, e.g. different spine types.
Our ultrastructural analysis of different areas of the adult brain
by immunogold labelling revealed that both PFNs are present in
pre- and postsynaptic compartments, with a distinctly more
intense labelling of the latter. This is consistent with a biochemical
study describing a high amount of PFN2a in isolated postsynaptic
Figure 2. Cell bodies and synaptic structures of cultured
embryonic neurons contain profilin 1 (PFN1) and profilin 2a
(PFN2a). Confocal images showing the simultaneous immunostaining
of PFN1 and PFN2a in a mouse hippocampal neuron (DIV14) with
monoclonal antibodies specific for each isoform, and with a rabbit
serum specific for the synaptic markers synapsin 1 and 2. Note that
both isoforms are concentrated in synapses (arrows, right panels). Bar:
10 mm.
doi:10.1371/journal.pone.0034167.g002
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PLoS ONE | www.plosone.org 5 March 2012 | Volume 7 | Issue 3 | e34167Figure 3. PFN1 and PFN2a are enriched at postsynaptic sites in the adult rat brain. (A): Ultrastructural localisation of PFN1 (upper row) and
2a (centre row) in the cortex (left column), CA1 region of the hippocampus (centre column) and cerebellar cortex (right column) as seen with pre-
embedding immunogold labelling. Immunogold labelling of synaptophysin (bottom rows), a presynaptic marker, served to demonstrate the
localisation of both profilin isoforms in synapses. Sp: dendritic spine. Bars: 50 nm. (B): Quantitation of PFN1 and PFN2a immunoreactivity in pre- and
postsynaptic structures in cortex, hippocampus and cerebellum. The Y-axis represents the percentage of pre- and postsynapses positive for gold
particles. Note that both isoforms are more densely concentrated in postsynaptic than in presynaptic structures. (25–50 synapses per experiment,
mean errors are based on 2 independent experiments; * P,0.05, statistical analysis by paired t-test).
doi:10.1371/journal.pone.0034167.g003
Figure 4. PFN2a is enriched in postsynaptic regions of inhibitory synapses. (A): Confocal images of neurons with simultaneous
immunostaining of PFN1 (left column), PFN2a (centre column) and gephyrin, a protein concentrated in the active zone of inhibitory postsynapses. (cf.
[2]). Note that PFN2a is frequently concentrated in gephyrin clusters, while PFN1 is rarely enriched in these structures (arrows). Right column: Higher
magnification of a neuron immunostained for PFN2a, gephyrin and VGAT, a marker for the inhibitory presynapse. Note that PFN2a primarily
colocalises with synaptic gephyrin clusters (arrows), whereas extra-synaptic gephyrin clusters, identified by lack of VGAT staining, are mostly negative
for PFN2a (arrow heads). Bar: 10 mm. (B): Quantitative analysis of the presence of PFN2a in synaptic and extra-synaptic gephyrin clusters (at least 483
extra-synaptic and 1830 synaptic gephyrin clusters per experiment, mean errors are based on 3 independent experiments, statistical analysis by
unpaired t test).
doi:10.1371/journal.pone.0034167.g004
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enrichment in postsynaptic fractions has also been reported [8].
Conceivably, the small, highly soluble profilins might be partially
lost during cell fractionation and thus, our ultrastructural analyses
more faithfully reflect the in vivo situation than biochemical studies.
Considering the role of profilin as modulator of actin dynamics
in nerve endings, the close proximity of PFN1 and PFN2a to
postsynaptic densities is well in line with recent studies that
demonstrate the presence of a large pool of dynamic actin in these
areas [38,39]. Furthermore, the prominent amounts of PFN2a in
postsynaptic structures throughout the cortex, hippocampus and
cerebellum suggest an important contribution of PFN2a to
physiological functions involving the postsynapse, although the
complex behavioural phenotype of pfn2-deficient mice has been
mainly attributed to defects in presynaptic membrane trafficking
[8,16].
Figure 5. Both isoforms are enriched in activated synapses. (A): Triple immunofluorescence images of cultured rat neurons either stimulated
with 70 mM KCl or kept under control conditions (-KCl), while incubated with antibodies against synaptotagmin 1. The total population of synapses
was identified by staining for piccolo (centre panels), while synapses with active synaptotagmin 1 uptake were identified by staining with the
corresponding antibody (uptake, left panels). Staining for PFN1 or PFN2a is shown in the right panels. Note that active synapses display a much more
prominent signal for PFN1 and PFN2a than inactive ones. Bar 5 mm. (B): Quantitative analysis of activity-dependent changes in PFN1- (left) or PFN2a-
(right) immunoreactivity in piccolo-positive synapses. The immunoreactivity of piccolo is independent of synaptic activity and thus serves as a
reference parameter for synaptic PFN1 and PFN2a. The Y-axis reflects the relative amounts of profilin at piccolo puncta. The graph shows the mean 6
SEM, n=200–500 terminals were analysed in 2–3 independent experiments; *P,0.05, **P,0.01, statistical analysis by paired t test. (C): Quantitative
analysis of PFN1 and PFN2a enrichment (i.e., the fluorescence signal at a synapse divided by this signal in the neurite) in dendritic spines of
hippocampal neurons after KCl stimulation with and without blocking of the postsynaptic (dendritic) NMDA-receptor by the antagonist APV
(100 mM). Note that inhibition of the NMDA receptor did not alter the level of PFN1 in dendritic spines, whereas PFN2a was significantly reduced. The
graph shows the mean 6 SEM, n=198–296 synapses were analysed; * P,0.05, ** P,0.01, *** P,0.005, statistical analysis by paired t test.
doi:10.1371/journal.pone.0034167.g005
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PLoS ONE | www.plosone.org 7 March 2012 | Volume 7 | Issue 3 | e34167The presence of profilins in inhibitory synapses was observed
before (see [2]) and suggests their participation in the regulation of
neurotransmitter receptor organisation and mobility at the
postsynaptic density, as executed by the actin cytoskeleton [1].
In addition to directly modulating actin dynamics in concert with
actin nucleators such as Ena/VASP and formins, profilin can form
complexes with gephyrin, a structural component of the
postsynaptic zone in inhibitory synapses [11,12]. There, gephyrin
is organised in clusters. Size and geometry of these structures are
regulated by the actin cytoskeleton, and determine the mobility of
glycine receptors and thus the efficiency of inhibitory signal
transmission [40,41]. Our study now provides detailed information
on the distribution of both isoforms in inhibitory synapses.
Although recombinant PFN1 and PFN2a can bind gephyrin with
comparable affinities in vitro [12], we found preferentially PFN2a
within the gephyrin clusters of inhibitory postsynaptic structures.
This finding suggests a specific role for PFN2a in inhibitory signal
transmission. Considering the functions of PFN2a in dendritic
spines [20] and kainate receptor dynamics [14], it is conceivable
that PFN2a may also modulate other aspects in inhibitory synapses
like the size and mobility of postsynaptic clusters. Notably, in
spinal cords, of PFN2a knockout mice the number and density of
gephyrin and glycine receptor clusters appear unaffected [8].
Clearly, further studies are required to unravel the nature of
PFN2a functions in inhibitory synapses.
It is undisputed that the activity and structural plasticity of
neurons is related to the organization and dynamics of actin in
synapses, particularly in dendritic spines [38,39,42]. Being potent
regulators of actin dynamics, profilins were thus assumed to
respond to neuronal activity in general, and indeed, several studies
have shown that the profilin levels in synaptic compartments
change with neuronal activity. For example, a significant rise in
the number of PFN1-positive synapses after KCl-based activation
was reported [10], and GFP-PFN2a targets to dendritic spines in
an activity-dependent manner [17]. In our current study we show
that both, PFN1 and PFN2a levels increase in KCl-activated
synapses but only PFN2a levels responded to NMDA receptor
activity. Hence, PFN1 and PFN2a address different signalling
pathways thus must have differential roles in the actin-dependent
regulation of neuronal architecture. One example of such a
differential role was already provided in our recent analysis of
dissociated neurons with altered profilin levels: PFN2a deficient
neurons display a significant reduction in dendritic complexity and
spine numbers. Only the latter can be rescued by overexpression
of PFN1 [20]. This study also revealed a differential association of
PFN1 and PFN2a with p75
NTR, a neurotrophin receptor engaged
in neuronal morphology by regulating the ROCK signalling
pathway [43]. In neurons displaying severe morphological changes
induced by p75
NTR overexpression, exogenous PFN1 or PFN2a
rescues either dendritic morphology or spine numbers, respectively
[20]. We now report on the association between profilins and an
additional pathway: The activation of BNDF dependent signalling
pathways changes the levels of both isoforms in synapses. Hence,
our data reveal the differential response of both isoforms to
different signals, which demonstrates the importance of these
isoforms for structural complexity of neurons.
Based on our data we cannot distinguish whether the elevated
levels of profilin are caused by recruitment or increased synthesis.
Blocking protein synthesis as a means to discriminate between
these alternatives was not possible, since the incubation time
required for a clear BDNF effect was 22 h, and neurons would not
tolerate inhibition of protein synthesis for such a long period of
time. However, a translocation of profilins induced by BDNF
seems possible, regarding the fact that the BDNF ligand TrkB
activates a signalling cascade, upstream of profilin. BDNF bound
TrkB receptors activate phospholipase Cc1 [44,45] which then is
capable of releasing membrane-bound profilin by PIP2 hydrolysa-
tion [46,47]. And indeed a BDNF-dependent change in spine
structure has been described and is dependent on TrkB activation
([32], see also [31]). In case of nuclear profilins, new synthesis
seems at least in part to contribute to nuclear PFN1 after BDNF
treatment, since the observed increase is not matched by a
simultaneous decrease of cytoplasmic PFN1 (Figure 7D).
The presence of profilins in the nuclear compartment was
described for cultured mammalian epithelial [48] and neuronal
cells [18,49] as well as for oocytes [50]. Accordingly, the nucleus
harbours a number of profilin ligands including nuclear actin [51],
splicing regulators [33,35,49] and transcription factors [34].
Here, we report that both, PFN1 and PFN2a are localized within
a neuronal nucleus, and that their respective levels respond
differentially to changes in neuronal activity. The functional
significance of their presence in the nucleus and a possible link
to synaptic transmission [18] needs to be addressed in future
studies.
Figure 6. BDNF treatment results in an enrichment of both profilin isoforms in synapses of hippocampal neurons. (A): Rat
hippocampal neurons at DIV9 were treated with BDNF or BSA as control (Co) for 22 hours, fixed and stained for the synaptic marker synapsin, PFN1 or
PFN2a. Bar: 3 mm. (B): Quantitative analysis of the enrichment factor. 250 to 400 synapses were quantified in 3 independent experiments for each PFN
isoform; mean 6 SEM; paired t test; * P,0.05.
doi:10.1371/journal.pone.0034167.g006
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Ethics Statement
The experimental protocols were carried out in accordance with
the Directive 2010/63/EU of the European Parliament and the
Council of the European Union of 22 September 2010 and all
procedures were approved by guidelines from the Animal
Committee on Ethics in the Care and Use of Laboratory Animals
of TU Braunschweig, Germany (033.42502-05-A-002/08).
Cell culture, neuronal stimulation and transfection
C2C12 myoblasts (ATCC: #CRL-1772) were grown according
to standard procedures. Primary cultures of mouse hippocampal
neurons were prepared from mouse embryos E18. Embryos were
decapitated and the brains were kept in ice-cold Gey’s balanced
salt solution supplemented with glucose. After dissection the
hippocampi were dissociated by 30 min incubation with trypsin
followed by mechanical separation using a Pasteur pipette. 10
5
Cells were seeded on poly-L-lysine coated cover slips and
incubated in Neurobasal medium (Invitrogen, Karlsruhe, Ger-
many) supplemented with 2% B27 (Invitrogen) and 0.5 mM
Glutamax at 37uC, 5% CO2 and 99% humidity. Cultures of rat
hippocampal neurons were prepared from E19 rat embryos by a
similar procedure [52] and cultivated for 14 days before fixation.
To study activity-dependent changes in PFN isoform localisa-
tion, three different protocols were used. (i) Dissociated rat neurons
were stimulated by depolarization with KCl, and activated
synapses were identified by the uptake of synaptotagmin
antibodies. Neurons were stimulated with 70 mM KCl in
depolarization buffer (44 mM NaCl, 2 mM CaCl2, 1 mM MgCl2,
20 mM Hepes, 30 mM glucose, pH 7.4) in the presence of
synaptotagmin1 antibodies for 90 sec, followed by 10 min
incubation with synaptotagmin1 antibodies in Neurobasal medi-
um. After three washes with medium, neurons were fixed and
stained for the uptake of synaptotagmin1 antibodies, for PFN1 or
PFN2a, and piccolo as described below. (ii) To study NMDA
receptor dependent changes in PFN isoform distribution, dissoci-
ated rat neurons were stimulated with 10 mM N-methyl-D-
aspartate (NMDA, Sigma-Aldrich, Munich, Germany) in Tyrode’s
solution for 30 min, as described [17,18]. The basic level of
stimulation was controlled by 30 min preincubation with 100 mM
(2R)-amino-5-phosphonovaleric acid (APV, Sigma-Aldrich), as
described [17,18]. (iii) Stimulation with the brain derived
neurotrophic factor BDNF was achieved by exposing the cultures
to BDNF (100 ng/ml, 22 h; R&D Systems, Minneapolis, MN) at
DIV9 as described [53,54]. For control treatment 1% BSA was
added to the medium. C2C12 myoblasts were transfected with
pEGFP-PFN2a using Fugene 6 (Roche Diagnostics, Mannheim,
Germany), accordingly to manufacturer’s instructions.
Antibodies
The PFN isoform-specific mouse monoclonal antibodies used in
this study were produced in our laboratory, according to standard
protocols. Hybridoma culture supernatants were used for
immunohistochemistry at the dilutions indicated. The monoclonal
PFN1 antibody (2C5; 1:10) was raised against a peptide sequence
corresponding to aa 5–18 of mouse PFN1, which was exposed on
the surface of self-assembling nanoparticles as described in [21].
The PFN2a monoclonal antibody (4H5; 1:75) was raised against
genuine PFN2a purified from bovine brain and characterized in
our laboratory [5]. The monoclonal antibody against gephyrin
(3B11; 1:50) was also raised and characterised in our laboratory
[55]. A monoclonal synaptophysin antibody (Sigma-Aldrich) and
the following polyclonal antibodies were used as neuronal markers:
Rabbit anti-synapsin and guinea pig anti-synapsin 1/2 (Synaptic
Systems, Go ¨ttingen, Germany, diluted 1:100 and 1:500, respec-
tively), rabbit anti-VGAT (Synaptic Systems, 1:100), rabbit anti-
piccolo (Synaptic Systems, 1:500), and guinea pig anti-synapto-
tagmin 1 (Synaptic Systems, 1:100). For indirect labelling, the
following secondary antibodies were used: Cross-adsorbed goat
anti-mouse IgG-Cy3 (Dianova, 1:100), goat anti-rabbit IgG-Cy2
(Dianova, 1:100), goat-anti guinea pig IgG-Alexa488 und -
Alexa549 (Mobitec Go ¨ttingen, Germany, 1:100) and goat anti-
rabbit IgG-Cy5 (Dianova, 1:100). To simultaneously label both
profilin isoforms in the same cell, one profilin antibody was
conjugated to the fluorophore by means of the anti-mouse IgG1-
Alexa488 Zenon-Kit (Invitrogen), prior to using it in standard
immunostaining protocols (see below).
Immunohistochemistry, Image Acquisition and Analysis
For indirect immunofluorescence, cultures of dispersed mouse
and rat hippocampal cells were fixed with 4% (w/v) formaldehyde
(FA) in phosphate-buffered saline (PBS) for 20 min, permeabilised
with 0.02% (v/v) Triton X-100 for 3 min, and then blocked with
1% (w/v) bovine serum albumin (Applichem, Darmstadt,
Germany) in PBS. For staining of individual PFN isoforms in
combination with neuronal markers, the fixed cultures were
incubated with the respective primary antibodies or serum for
60 min, followed by secondary antibodies for 45 min. Staining
with DAPI (Sigma-Aldrich, 1:1000) was performed afterwards for
5 min in PBS where indicated. Images were acquired using a
SPOT cooled CCD camera (Visitron Systems, Puchheim,
Germany) attached to a Zeiss Axiovert 200 M microscope (Zeiss,
Go ¨ttingen, Germany). Images were collected using 636and 1006
Plan-Neofluar oil objectives and digital images were analysed with
Metamorph (Molecular Devices, Sunnyvale, USA). To quantify
fluorescent intensities, we applied equal thresholds to all images
within the respective experiment. Prior to the implementation of
thresholds, background intensity was subtracted. Fluorescent
intensity was measured in a defined area within the synaptic
terminal and for enrichment factor calculation in the dendrite. For
comparative measurements of nuclear and cytosolic profilin, the
outlines of nuclei were determined by DAPI staining and
cytoplasmic regions of neurite branching were not taken into
account.
Simultaneous labelling with two mouse monoclonal antibodies
was performed as follows. After indirect staining of the first antigen,
the second antigen was labelled with fluorochromed Fab fragments
bound to the Fc-portion of the respective primary antibody. These
complexes, ‘‘Zenon-Fab fragments’’, were prepared according to
Figure 7. BDNF treatment results in an enrichment of PFN1 in nuclei of rat hippocampal neurons. (A): Images of non-stimulated (co) and
stimulated (BDNF) hippocampal neuronal cell bodies stained for PFN1 and PFN2a and counterstained with DAPI. Bar: 10 mm. (B, C): Rat hippocampal
neurons at DIV14 were treated with KCl in the presence and absence of the antagonist APV. Statistical analysis of profilin levels in the nucleus and the
cytoplasm as monitored by immunofluorescence, in relation to synaptic activity. (B): fluorescence intensity of nuclear and cytoplasmic areas with and
without KCl stimulation. (C): Analogous analysis with and without blocking the postsynaptic NMDA receptor by the antagonist APV. Paired t test;
*P ,0.05, ** P,0.01, *** P,0.005 (28–60 cells (B), respectively 100–129 (C) cells from 2 to 3 independent experiments were analysed). (D):
Fluorescence intensity in the nuclear and the cytoplasmic compartment of neurons treated with BDNF or BSA (co) at DIV9. Paired t test; ** P,0.01
(30–50 cells from 3 independent experiments were analysed).
doi:10.1371/journal.pone.0034167.g007
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1 mg oftheprimary antibodywasincubated with 6 mg ofthe Zenon-
labelling solution for 5 minutes. After adsorbing unbound fluor-
ochromed Fab-fragments by the addition of unspecific mouse IgG
for 5 minutes, the now labelled primary monoclonal antibodies
were added to the coverslips and incubated for 30 minutes.
Unbound antibodies were removed by washing three times with
PBS. Translocation of Alexa-488 conjugated Zenon Fab-fragments
in the cells was prevented by additional fixation with 4% FA in PBS
for 15 minutes. The specificity of this method was confirmed in
control experiments showing a discrete labelling with two mouse
monoclonal antibodies of a cytoplasmic and a mitochondrial
protein in the same cell (data not shown). Cells were examined by
confocal laser scanning microscopy (LSM 510 Meta, Zeiss,
Go ¨ttingen, Germany), by using multitrack technique to monitor
individual channels separately.
The PFN localisation in the mature rat brain (hippocampus,
cortex and cerebellum) was examined at the ultrastructural level
by immunoelectron microscopy. Adult rats (Wistar) were anaes-
thetized and perfused with PBS, followed by 4% (w/v) FA in PBS.
The brain was dissected and cut into 100 mm sagittal sections on a
Vibratome. The sections were cryoprotected in 30% (w/v) sucrose,
repeatedly frozen and thawed, collected in PBS, processed free-
floating, blocked with 5% FCS in PBS for 1 h and then incubated
with the PFN antibodies 2C5 or 4H5 and with anti-synaptophysin.
Subsequently, the sections were incubated with rabbit-anti-mouse
IgG for 5 h, washed in PBS and incubated with Protein A-gold
(5 nm) overnight at 4uC. After an additional wash with PBS, the
sections were postfixed with 1% osmium tetroxide, dehydrated
and flat-embedded in Epon 812, prior to cutting 90 nm sections
on a Reichert Ultracut S (Leica) microtome. Specimens were
examined in a LEO 906 electron microscope (Zeiss, Oberkochen,
Germany). For quantification synapses positive for gold particles at
the pre-or postsynaptic compartment and at both compartments
simultaneously were included for analysis.
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